APO Research

APO RESEARCH · REPORT

Halitosis Treatment

Selected research

Market Analysis & Forecast

Global Halitosis Treatment Market Analysis and Forecast 2026-2032

Market perspective

The global Halitosis Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Halitosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Halitosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Halitosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Halitosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Halitosis Treatment include Abbott, AstraZeneca, Rowpar Pharmaceuticals, Listerine, Dr. Harold Katz and Colgate-Palmolive Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Halitosis Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Halitosis Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Halitosis Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Halitosis Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Halitosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Halitosis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Halitosis Treatment Segment by Company

Abbott

AstraZeneca

Rowpar Pharmaceuticals

Listerine

Dr. Harold Katz

Colgate-Palmolive Company

Halitosis Treatment Segment by Type

Pathologic Halitosis

Others

Halitosis Treatment Segment by Application

Hospitals

Clinics

Halitosis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Halitosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Halitosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Halitosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Halitosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Halitosis Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Halitosis Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Halitosis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pathologic Halitosis Major Player Table 3. Others Major Player Table 4. Global Halitosis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Clinics Major Player Table 7. Halitosis Treatment Industry Trends Table 8. Halitosis Treatment Industry Drivers Table 9. Halitosis Treatment Industry Opportunities and Challenges Table 10. Halitosis Treatment Industry Restraints Table 11. Global Halitosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Halitosis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Halitosis Treatment Market Share by Region (2021-2026) Table 14. Global Halitosis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Halitosis Treatment Market Share by Region (2027-2032) Table 16. Global Halitosis Treatment Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Halitosis Treatment Revenue Market Share by Players (2021-2026) Table 18. Global Halitosis Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Halitosis Treatment Key Players Headquarters & Area Served Table 20. Global Halitosis Treatment Players, Product Type & Application Table 21. Global Halitosis Treatment Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Halitosis Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Halitosis Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Halitosis Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Halitosis Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Halitosis Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Halitosis Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Halitosis Treatment Revenue Market Share by Application (2027-2032) Table 34. Abbott Company Information Table 35. Abbott Business Overview Table 36. Abbott Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Abbott Halitosis Treatment Product Portfolio Table 38. Abbott Recent Development Table 39. AstraZeneca Company Information Table 40. AstraZeneca Business Overview Table 41. AstraZeneca Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. AstraZeneca Halitosis Treatment Product Portfolio Table 43. AstraZeneca Recent Development Table 44. Rowpar Pharmaceuticals Company Information Table 45. Rowpar Pharmaceuticals Business Overview Table 46. Rowpar Pharmaceuticals Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Rowpar Pharmaceuticals Halitosis Treatment Product Portfolio Table 48. Rowpar Pharmaceuticals Recent Development Table 49. Listerine Company Information Table 50. Listerine Business Overview Table 51. Listerine Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Listerine Halitosis Treatment Product Portfolio Table 53. Listerine Recent Development Table 54. Dr. Harold Katz Company Information Table 55. Dr. Harold Katz Business Overview Table 56. Dr. Harold Katz Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Dr. Harold Katz Halitosis Treatment Product Portfolio Table 58. Dr. Harold Katz Recent Development Table 59. Colgate-Palmolive Company Company Information Table 60. Colgate-Palmolive Company Business Overview Table 61. Colgate-Palmolive Company Halitosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Colgate-Palmolive Company Halitosis Treatment Product Portfolio Table 63. Colgate-Palmolive Company Recent Development Table 64. North America Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Halitosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Halitosis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Halitosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Halitosis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 78. China Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 79. China Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 80. China Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 81. China Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Halitosis Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Halitosis Treatment Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Halitosis Treatment Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Halitosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Halitosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Halitosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Halitosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Halitosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Halitosis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Halitosis Treatment Image Figure 2. Global Halitosis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Halitosis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pathologic Halitosis Image Figure 5. Others Image Figure 6. Global Halitosis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Halitosis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Global Halitosis Treatment Market Size (US$ Million) & (2021-2032) Figure 11. Global Halitosis Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Halitosis Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Halitosis Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Halitosis Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Halitosis Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Halitosis Treatment Revenue Market Share by Type (2021-2032) Figure 18. Global Halitosis Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Halitosis Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Halitosis Treatment Revenue Market Share by Application (2021-2032) Figure 21. North America Halitosis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Halitosis Treatment Revenue Share by Type (2021-2032) Figure 23. North America Halitosis Treatment Revenue Share by Application (2021-2032) Figure 24. North America Halitosis Treatment Revenue Share by Country (2021-2032) Figure 25. United States Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Halitosis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Halitosis Treatment Revenue Share by Type (2021-2032) Figure 30. Europe Halitosis Treatment Revenue Share by Application (2021-2032) Figure 31. Europe Halitosis Treatment Revenue Share by Country (2021-2032) Figure 32. Germany Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Halitosis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Halitosis Treatment Revenue Share by Type (2021-2032) Figure 42. China Halitosis Treatment Revenue Share by Application (2021-2032) Figure 43. Asia Halitosis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Halitosis Treatment Revenue Share by Type (2021-2032) Figure 45. Asia Halitosis Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Halitosis Treatment Revenue Share by Region (2021-2032) Figure 47. Japan Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Halitosis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Halitosis Treatment Revenue Share by Type (2021-2032) Figure 55. SAMEA Halitosis Treatment Revenue Share by Application (2021-2032) Figure 56. SAMEA Halitosis Treatment Revenue Share by Country (2021-2032) Figure 57. Brazil Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Halitosis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Pathologic Halitosis
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Abbott
  • AstraZeneca
  • Rowpar Pharmaceuticals
  • Listerine
  • Dr. Harold Katz
  • Colgate-Palmolive Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Halitosis Treatment Market by Type
  3. 1.2.1 Global Halitosis Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pathologic Halitosis
  5. 1.2.3 Others
  6. 1.3 Halitosis Treatment Market by Application
  7. 1.3.1 Global Halitosis Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Halitosis Treatment Market Dynamics
  1. 2.1 Halitosis Treatment Industry Trends
  2. 2.2 Halitosis Treatment Industry Drivers
  3. 2.3 Halitosis Treatment Industry Opportunities and Challenges
  4. 2.4 Halitosis Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Halitosis Treatment Market Perspective (2021-2032)
  2. 3.2 Global Halitosis Treatment Growth Trends by Region
  3. 3.2.1 Global Halitosis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Halitosis Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Halitosis Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Halitosis Treatment Revenue by Players
  2. 4.1.1 Global Halitosis Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Halitosis Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Halitosis Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Halitosis Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Halitosis Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Halitosis Treatment Players, Product Type & Application
  8. 4.5 Global Halitosis Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Halitosis Treatment Market CR5 and HHI
  11. 4.6.3 2025 Halitosis Treatment Tier 1, Tier 2, and Tier 3
5 Halitosis Treatment Market Size by Type
  1. 5.1 Global Halitosis Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Halitosis Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Halitosis Treatment Revenue Market Share by Type (2021-2032)
6 Halitosis Treatment Market Size by Application
  1. 6.1 Global Halitosis Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Halitosis Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Halitosis Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Halitosis Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Halitosis Treatment Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Halitosis Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Halitosis Treatment Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Rowpar Pharmaceuticals
  14. 7.3.1 Rowpar Pharmaceuticals Company Information
  15. 7.3.2 Rowpar Pharmaceuticals Business Overview
  16. 7.3.3 Rowpar Pharmaceuticals Halitosis Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Rowpar Pharmaceuticals Halitosis Treatment Product Portfolio
  18. 7.3.5 Rowpar Pharmaceuticals Recent Developments
  19. 7.4 Listerine
  20. 7.4.1 Listerine Company Information
  21. 7.4.2 Listerine Business Overview
  22. 7.4.3 Listerine Halitosis Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Listerine Halitosis Treatment Product Portfolio
  24. 7.4.5 Listerine Recent Developments
  25. 7.5 Dr. Harold Katz
  26. 7.5.1 Dr. Harold Katz Company Information
  27. 7.5.2 Dr. Harold Katz Business Overview
  28. 7.5.3 Dr. Harold Katz Halitosis Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Dr. Harold Katz Halitosis Treatment Product Portfolio
  30. 7.5.5 Dr. Harold Katz Recent Developments
  31. 7.6 Colgate-Palmolive Company
  32. 7.6.1 Colgate-Palmolive Company Company Information
  33. 7.6.2 Colgate-Palmolive Company Business Overview
  34. 7.6.3 Colgate-Palmolive Company Halitosis Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Colgate-Palmolive Company Halitosis Treatment Product Portfolio
  36. 7.6.5 Colgate-Palmolive Company Recent Developments
8 North America
  1. 8.1 North America Halitosis Treatment Revenue (2021-2032)
  2. 8.2 North America Halitosis Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Halitosis Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Halitosis Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Halitosis Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Halitosis Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Halitosis Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Halitosis Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Halitosis Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Halitosis Treatment Revenue by Country
  11. 8.6.1 North America Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Halitosis Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Halitosis Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Halitosis Treatment Revenue (2021-2032)
  2. 9.2 Europe Halitosis Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Halitosis Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Halitosis Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Halitosis Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Halitosis Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Halitosis Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Halitosis Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Halitosis Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Halitosis Treatment Revenue by Country
  11. 9.6.1 Europe Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Halitosis Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Halitosis Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Halitosis Treatment Revenue (2021-2032)
  2. 10.2 China Halitosis Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Halitosis Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Halitosis Treatment Revenue by Type (2027-2032)
  5. 10.3 China Halitosis Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Halitosis Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Halitosis Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Halitosis Treatment Revenue by Application (2027-2032)
  9. 10.5 China Halitosis Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Halitosis Treatment Revenue (2021-2032)
  2. 11.2 Asia Halitosis Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Halitosis Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Halitosis Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Halitosis Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Halitosis Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Halitosis Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Halitosis Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Halitosis Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Halitosis Treatment Revenue by Country
  11. 11.6.1 Asia Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Halitosis Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Halitosis Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Halitosis Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Halitosis Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Halitosis Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Halitosis Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Halitosis Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Halitosis Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Halitosis Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Halitosis Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Halitosis Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Halitosis Treatment Revenue by Country
  11. 12.6.1 SAMEA Halitosis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Halitosis Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Halitosis Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research